Granata, Simona
 Distribuzione geografica
Continente #
EU - Europa 1.276
NA - Nord America 1.267
AS - Asia 1.014
SA - Sud America 224
AF - Africa 24
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.810
Nazione #
US - Stati Uniti d'America 1.240
IE - Irlanda 465
SG - Singapore 420
RU - Federazione Russa 320
CN - Cina 221
SE - Svezia 214
HK - Hong Kong 172
BR - Brasile 170
VN - Vietnam 109
FR - Francia 76
IT - Italia 56
DE - Germania 46
AR - Argentina 26
GB - Regno Unito 25
FI - Finlandia 21
IN - India 15
CA - Canada 14
BD - Bangladesh 12
IQ - Iraq 12
EC - Ecuador 10
ID - Indonesia 9
NL - Olanda 8
JP - Giappone 7
MX - Messico 7
UA - Ucraina 7
AZ - Azerbaigian 6
CL - Cile 6
JO - Giordania 6
CZ - Repubblica Ceca 5
PL - Polonia 5
TR - Turchia 5
ZA - Sudafrica 5
AT - Austria 4
EG - Egitto 4
ES - Italia 4
KE - Kenya 4
LT - Lituania 4
PK - Pakistan 4
AU - Australia 3
CO - Colombia 3
NO - Norvegia 3
PT - Portogallo 3
TH - Thailandia 3
UY - Uruguay 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DZ - Algeria 2
MA - Marocco 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BZ - Belize 1
CH - Svizzera 1
ET - Etiopia 1
GM - Gambi 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
SD - Sudan 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 3.810
Città #
Dublin 465
San Jose 331
Ashburn 193
Nyköping 175
Hong Kong 171
Singapore 160
Chandler 102
Beijing 95
Santa Clara 70
Lauterbourg 61
Moscow 55
Princeton 48
Dallas 42
Ho Chi Minh City 32
Hanoi 29
Los Angeles 29
Wilmington 29
Boardman 21
Des Moines 19
Helsinki 18
New York 18
Washington 17
Frankfurt am Main 12
Munich 12
São Paulo 11
Bari 8
Brasília 8
Brooklyn 8
Curitiba 8
Nuremberg 8
The Dalles 8
Baghdad 7
Guangzhou 7
Stockholm 7
Amman 6
Baku 6
Boston 6
Cape Coral 6
Charlotte 6
Falkenstein 6
Rio de Janeiro 6
Chennai 5
London 5
Portsmouth 5
Toronto 5
Warsaw 5
Biên Hòa 4
Brno 4
Campinas 4
Chicago 4
Düsseldorf 4
Genova 4
Haiphong 4
Quito 4
Raleigh 4
Shanghai 4
Sorocaba 4
Vittuone 4
Wuhan 4
Buenos Aires 3
Cairo 3
Council Bluffs 3
Guayaquil 3
Johannesburg 3
Manaus 3
Manchester 3
Montevideo 3
Montreal 3
Naples 3
Porto Alegre 3
San Miguel de Tucumán 3
San Severo 3
Seattle 3
Tokyo 3
Turku 3
Amsterdam 2
Ankara 2
Bangkok 2
Blumenau 2
Can Tho 2
Cao Lanh 2
Caraguatatuba 2
Cleveland 2
Clifton 2
Coimbra 2
Cotia 2
Crotone 2
Da Nang 2
Duque de Caxias 2
Foggia 2
Fortaleza 2
Fukuoka 2
Garden City 2
Goiânia 2
Gramado 2
Ha Long 2
Istanbul 2
Karachi 2
Kemerovo 2
Meina 2
Totale 2.501
Nome #
Oxidative Stress and Ischemia/Reperfusion Injury in Kidney Transplantation: Focus on Ferroptosis, Mitophagy and New Antioxidants 89
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 88
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase 87
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients 87
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 86
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells 86
A Comprehensive Proteomics Analysis of Urinary Extracellular Vesicles Identifies a Specific Kinase Protein Profile as a Novel Hallmark of Medullary Sponge Kidney Disease 86
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 84
Kidney Allograft Fibrosis: What We Learned From Latest Translational Research Studies 84
From pharmacogenetics to pharmacogenomics: the birth of a new era of personalized medicine in nephrology 84
Analysis of urinary exosomes applications for rare kidney disorders 83
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients 83
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen 82
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation 80
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients 80
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 79
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease 79
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 78
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 77
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 76
Dialysis-related transcriptomic profiling: The pivotal role of heparanase 76
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease 74
Proteomics insights into medullary sponge kidney (MSK) disease: review of the recent results of an Italian research collaborative network 73
Dialysis-related systemic microinflammation is associated with specific genomic patterns 73
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 72
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury 72
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients 72
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 68
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 67
Association between NLRP3 rs10754558 and CARD8 rs2043211 Variants and Susceptibility to Chronic Kidney Disease 64
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients 64
Recent Advances in the Role of Natural Killer Cells in Acute Kidney Injury 63
The Genetic Architecture of Membranous Nephropathy and Its Potential to Improve Non-Invasive Diagnosis 62
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 60
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. 55
mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation 53
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease 52
Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease 52
Proteomic profile of mesothelial exosomes isolated from peritoneal dialysis effluent of children with focal segmental glomerulosclerosis 51
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease 51
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells 50
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors 50
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets 49
PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings 49
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients 48
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation 48
Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease 47
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine 47
mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis 46
Proteomic analysis of urinary extracellular vesicles of kidney transplant recipients with BKV viruria and viremia: A pilot study 46
Autophagy Activation in Peripheral Blood Mononuclear Cells of Peritoneal Dialysis Patients 46
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition 46
mTOR Inhibition Role in Cellular Mechanisms 45
Mitochondria: a new therapeutic target in chronic kidney disease 45
mTOR inhibitors and renal allograft: Yin and Yang 45
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease 45
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 45
mRNA as a medicine in nephrology: the future is now. 44
Monoclonal antibody therapy and renal transplantation: focus on adverse effects 42
Skin cancer in solid organ transplant recipients: still an open problem 38
Proteomics reveals specific biological changes induced by the normothermic machine perfusion of donor kidneys with a significant up-regulation of Latexin 38
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 37
Inflammasome pathway in kidney transplantation 32
Immune abnormalities in IgA nephropathy 29
Totale 3.989
Categoria #
all - tutte 31.238
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.238


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022316 0 0 0 0 0 0 55 24 40 115 1 81
2022/2023937 83 19 37 10 44 84 3 106 497 6 32 16
2023/2024257 22 8 20 6 24 78 0 1 0 14 0 84
2024/2025829 48 13 11 13 20 189 46 46 271 60 88 24
2025/20261.650 75 183 230 297 79 56 374 197 80 79 0 0
Totale 3.989